Authors:
Mahalati, K
Belitsky, P
West, K
Kiberd, B
Fraser, A
Sketris, I
Macdonald, AS
McAlister, V
Lawen, J
Citation: K. Mahalati et al., Approaching the therapeutic window for cyclosporine in kidney transplantation: A prospective study, J AM S NEPH, 12(4), 2001, pp. 828-833
Authors:
Keown, P
Cole, E
Landsberg, D
Shapiro, J
Halloran, P
Muirhead, N
Lawen, J
Zaltzman, J
Murphy, GF
Tan, A
Balshaw, R
Primmett, D
Ngai, J
Hendricks, L
DuBois-Laviolette, A
Citation: P. Keown et al., Absorption profiling of cyclosporine microemulsion (Neoral) during the first 2 weeks after renal transplantation, TRANSPLANT, 72(6), 2001, pp. 1024-1032
Authors:
Barama, A
Oza, U
Panek, R
Belitsky, P
MacDonald, AS
Lawen, J
McAlister, V
Kiberd, B
Citation: A. Barama et al., Effect of recipient sensitization (peak PRA) on graft outcome in haploidentical living related kidney transplants, CLIN TRANSP, 14(3), 2000, pp. 212-217
Authors:
Mahalati, K
Belitsky, P
West, K
Kiberd, B
MacDonald, A
McAlister, V
Lawen, J
Citation: K. Mahalati et al., A 3-hour postdose cyclosporine level during the first week after kidney transplantation predicts acute rejection and cyclosporine nephrotoxicity moreaccurately than trough levels, TRANSPLAN P, 32(4), 2000, pp. 786-787
Authors:
Mahalati, K
Lawen, J
Kiberd, B
Belitsky, P
Citation: K. Mahalati et al., Is 3-hour cyclosporine blood level superior to trough level in early post-renal transplantation period?, J UROL, 163(1), 2000, pp. 37-41